These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8818119)

  • 21. Health values of adolescents with cystic fibrosis.
    Yi MS; Britto MT; Wilmott RW; Kotagal UR; Eckman MH; Nielson DW; Kociela VL; Tsevat J
    J Pediatr; 2003 Feb; 142(2):133-40. PubMed ID: 12584533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of disease impact in patients with intermittent claudication: discrepancy between health status and quality of life.
    Breek JC; de Vries J; van Heck GL; van Berge Henegouwen DP; Hamming JF
    J Vasc Surg; 2005 Mar; 41(3):443-50. PubMed ID: 15838478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examination of assumptions in using time tradeoff and standard gamble utilities in individuals with spinal cord injury.
    Lin MR; Yu WY; Wang SC
    Arch Phys Med Rehabil; 2012 Feb; 93(2):245-52. PubMed ID: 22289233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life in patients with intermittent claudication: relationship with laboratory exercise performance.
    Barletta G; Perna S; Sabba C; Catalano A; O'Boyle C; Brevetti G
    Vasc Med; 1996; 1(1):3-7. PubMed ID: 9546911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of intermittent claudication on quality of life. The Scottish Vascular Audit Group.
    Pell JP
    Eur J Vasc Endovasc Surg; 1995 May; 9(4):469-72. PubMed ID: 7633995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of time-tradeoff utilities and rating scale values of cancer patients and their relatives: evidence for a possible plateau relationship.
    O'Leary JF; Fairclough DL; Jankowski MK; Weeks JC
    Med Decis Making; 1995; 15(2):132-7. PubMed ID: 7783573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
    Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
    J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correcting biases in standard gamble and time tradeoff utilities.
    van Osch SM; Wakker PP; van den Hout WB; Stiggelbout AM
    Med Decis Making; 2004; 24(5):511-7. PubMed ID: 15359000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome impairs physical function, health-related quality of life, and peripheral circulation in patients with intermittent claudication.
    Gardner AW; Montgomery PS; Parker DE
    J Vasc Surg; 2006 Jun; 43(6):1191-6; discussion 1197. PubMed ID: 16765237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preference-based quality of life in patients with cerebral aneurysms.
    King JT; Tsevat J; Roberts MS
    Stroke; 2005 Feb; 36(2):303-9. PubMed ID: 15653579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assessment of the quality of life of patients with peripheral vascular diseases].
    Wohlgemuth WA; Niechzial M; Nagel E; Bohndorf K
    Rofo; 2003 Feb; 175(2):169-75. PubMed ID: 12584614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired health status and invasive treatment in peripheral arterial disease: a prospective 1-year follow-up study.
    Aquarius AE; Denollet J; Hamming JF; Breek JC; De Vries J
    J Vasc Surg; 2005 Mar; 41(3):436-42. PubMed ID: 15838477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility assessment among cataract surgery patients.
    Saw SM; Gazzard G; Gomezperalta C; Au Eong KG; Seah S
    J Cataract Refract Surg; 2005 Apr; 31(4):785-91. PubMed ID: 15899457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise-based interventions and health-related quality of life in intermittent claudication: a 20-year (1989-2008) review.
    Guidon M; McGee H
    Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):140-54. PubMed ID: 20215969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the preferences of patients with psoriasis. A quantitative, utility approach.
    Zug KA; Littenberg B; Baughman RD; Kneeland T; Nease RF; Sumner W; O'Connor GT; Jones R; Morrison E; Cimis R
    Arch Dermatol; 1995 May; 131(5):561-8. PubMed ID: 7741543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease.
    Myers SA; Johanning JM; Stergiou N; Lynch TG; Longo GM; Pipinos II
    J Vasc Surg; 2008 Mar; 47(3):550-555. PubMed ID: 18207355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preference-based measurement of health-related quality of life (HRQL) in children with chronic musculoskeletal disorders (MSKDs).
    Brunner HI; Maker D; Grundland B; Young NL; Blanchette V; Stain AM; Feldman BM
    Med Decis Making; 2003; 23(4):314-22. PubMed ID: 12926581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of including quality of life responses in models to predict walking performance of patients with intermittent claudication.
    Leicht AS; Crowther RG; Muller R; Golledge J
    Eur J Vasc Endovasc Surg; 2011 Apr; 41(4):511-7. PubMed ID: 21247784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.